Neuralink competitor uses real human neurons to improve their BMI
The connections between a Brain Machine Interface and the human brain are vital, and increasingly teams aren't using traditional methods or materials.
Key takeaways
- While companies like Neuralink have recently provided some flashy demos of what could be achieved by hooking brains up to computers, the technology still has serious limitations preventing wider use.
- Non-invasive approaches like Electroencephalograms (EEGs) provide only coarse readings of neural signals, limiting their functionality.
- California-based startup Science Corporation thinks that an implant using living neurons to connect to the brain could better balance safety and precision.
Cite or link to this article
Griffin, M. (2025) 'Neuralink competitor uses real human neurons to improve their BMI', 311 Institute, 18 January. Available at: https://www.311institute.com/neuralink-competitor-uses-real-human-neurons-to-improve-their-bmi/ (Accessed: 1 October 2026).
Brain implants have improved dramatically in recent years, and they're helping people become almost super-human, but they’re still invasive and unreliable. Now a new kind of Brain Machine Interface (BMI), which follows on from Chinese scientists using genetic engineering to improve their BMIs, is using living neurons to form connections could be the future.
While companies like Neuralink have recently provided some flashy demos of what could be achieved by hooking brains up to computers, the technology still has serious limitations preventing wider use.
Non-invasive approaches like Electroencephalograms (EEGs) provide only coarse readings of neural signals, limiting their functionality. Directly implanting electrodes in the brain can provide a much clearer connection, but such risky medical procedures are hard to justify for all but the most serious conditions.
California-based startup Science Corporation thinks that an implant using living neurons to connect to the brain could better balance safety and precision. In recent non-peer-reviewed research posted on bioarXiv, the group showed a prototype device could connect with the brains of mice and even let them detect simple light signals.
“The principal advantages of a biohybrid implant are that it can dramatically change the scaling laws of how many neurons you can interface with versus how much damage you do to the brain,” Alan Mardinly, director of biology at Science Corporation, told New Scientist.
The company’s CEO Max Hodak is a former president of Neuralink, and his company also produces a retinal implant using more conventional electronics that can restore vision in some patients. But the company has been experimenting with so-called “biohybrid” approaches, which Hodak thinks could provide a more viable long-term solution for BMI.
“Placing anything into the brain inevitably destroys some amount of brain tissue,” he wrote in a recent blog post. “Destroying 10,000 cells to record from 1,000 might be perfectly justified if you have a serious injury and those thousand neurons create a lot of value - but it really hurts as a scaling characteristic.”
Instead, the company has developed a honeycomb-like structure made of silicon featuring more than 100,000 “microwells” - cylindrical holes roughly 15 micrometers deep. Individual neurons are inserted into each of these microwells, and the array can then be surgically implanted onto the surface of the brain.
The idea is that while the neurons remain housed in the implant, their axons - long strands that carry nerve signals away from the cell body - and their dendrites - the branched structures that form synapses with other cells - will be free to integrate with the host’s brain cells.
To see if the idea works in practice they installed the device in mice, using neurons genetically modified to react to light. Three weeks after implantation, they carried out a series of experiments where they trained the mice to respond whenever a light was shone on the device. The mice were able to detect when this happened, suggesting the light-sensitive neurons had merged with their native brain cells.
While it’s early days, the approach has significant benefits. You can squeeze a lot more neurons into a millimeter-scale chip than electrodes and each of those neurons can form many connections. That means the potential bandwidth of a biohybrid device could be much more than a conventional neural implant. The approach is also much less damaging to the patient’s brain.
However, the lifetime of these kinds of devices could be a concern - after 21 days, only 50 percent of the neurons had survived. And the company needs to find a way to ensure the neurons don’t illicit a negative immune response in the patient.
If the approach works though, it could be an elegant and potentially safer way to merge man and machine.
FAQ
Why does this matter?
The connections between a Brain Machine Interface and the human brain are vital, and increasingly teams aren't using traditional methods or materials.

About the author
Matthew Griffin Founder, 311 Institute
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath."
Read full bio
Matthew Griffin is a multi-award winning Futurist and expert in Disruption and Innovation, Geopolitics, Leadership, and Technology, who NASA have described as a "walking encyclopaedia of the future" and a "futurist Polymath." 15-time best selling author of the "Codex of the Future" series, Matthew is the Founder and Futurist in Chief of the 311 Institute, a global Futures and Deep Futures advisory firm working with royal households, world leaders, G7, G20, and G77 governments, NGOs, and multi-national mid and mega cap firms to help them explore, shape, and lead the next 50 years of business and society.
An award-winning YouTube creator with over a million followers, with an unrivalled global reach and impact, Matthew is a highly sought-after international keynote speaker, lecturer, and mentor who collaborates with global leaders through the United Nations Alliance of Civilizations (UNAOC) and United Nations General Assembly (UNGA) to shape pivotal initiatives such as the UN’s AI for Humanity program, the United Nations Conference of the Parties (UN COP), and the World Economic Forum in Davos.
As the former Global Head of Cloud, National Security, and Enterprise Sales for companies including Atos, Dell-EMC, and IBM, Matthew has a proven track record of building multi-billion dollar business units and turning failing divisions into market leaders. His ability to identify, analyse, and communicate the implications of hundreds of emerging technologies and trends is unparalleled, and his insights are trusted by many of the world’s most respected organisations, including ABB, Accenture, Adidas, AON, ARM, BCG, Centrica, Citi, Coca-Cola, Dentons, Deloitte, Dow Jones, EY, Google, KPMG, Lego, Legal & General, LinkedIn, Microsoft, PepsiCo, Qualcomm, RWE, Samsung, Siemens AG and Siemens Energy, T-Mobile, UBS, VISA, Walmart, Workday, Worldpay and many others.
Regularly featured in the global media including the AP, BBC, Bloomberg, CNBC, Discovery, Forbes, Khaleej Times, Telegraph, TIME, ViacomCBS, WIRED, and the WSJ, Matthews mission is to help organisations create a fair and sustainable future whose benefits are shared by everyone irrespective of their ability, background, or circumstances.
What future do you need to see?
Choose one to get started on biotech and enhanced humans and the future of your organisation.
Sources and further reading
- recent non-peer-reviewed research biorxiv.org
- told New Scientist newscientist.com
- recent blog post science.xyz
Source: first published by the 311 Institute on 18 January 2025. Cite as: Griffin, M. (2025). Neuralink competitor uses real human neurons to improve their BMI. 311 Institute. https://www.311institute.com/neuralink-competitor-uses-real-human-neurons-to-improve-their-bmi/
You are welcome to quote this article with credit and a link to the original.